<DOC>
	<DOCNO>NCT02528721</DOCNO>
	<brief_summary>The Exalenz Dual Mode BreathID® Hp System comprise IDkit : Hp™ TWO Dual Mode BreathID® Hp test device use perform urea breath test initial diagnosis post treatment monitoring H.pylori infection adult patient result compare biopsy result .</brief_summary>
	<brief_title>Exalenz Lab Mode System Compared Biopsy H.Pylori Detection</brief_title>
	<detailed_description>Patients undergo esophagogastroduodenoscopy ( EGD ) initial diagnosis H.pylori infection post therapy confirmation eradication eligible participate trial . Two set biopsies take : one set histological analysis one set rapid urease test ( RUT ) analysis . The two result use gold standard composite score determine presence H.pylori bacteria stomach . The Urea Breath Test ( UBT ) use Exalenz Dual Mode BreathID Hp System also perform within week biopsy . The outcome UBT compare composite score biopsy accuracy UBT evaluate . The UBT perform use breath collection bag , subject ask breathe bag ingestion 13C-labelled urea .</detailed_description>
	<mesh_term>Helicobacter Infections</mesh_term>
	<criteria>Be least 18 year age . Have ability willingness sign Informed Consent Form . Present clinical indication H. pylorus candidate upper endoscopy For Initial Diagnosis arm : • Symptomatic patient naïve H.pylori treatment past 18 month For PostTherapy arm : Documented biopsy positive outcome prior eradication therapy ( include method determination ) Documented eradication therapy within past 6 month complete least 6 week prior UBT Participation interventional trial . Antibiotics and/or Bismuth preparation within four ( 4 ) week prior breath test . PPI H2 blocker within two ( 2 ) week prior breath test . Pregnant breastfeed woman . Allergy test substrate . Patient fast hour prior UBT</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
</DOC>